High blood pressure, also known as hypertension, is one of the most common health problems in the world. It affects tens of ...
A new study from researchers at the University of Virginia has revealed an important discovery that may help scientists develop improved treatments for high blood pressure in the future. The research ...
Aisa Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapies for systemic sclerosis, today announced results from its Phase 2 RECONNOITER trial of AISA-021 (cilnidipine), a novel ...
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced. The rapid-acting L-type calcium ...
Aisa Pharma announces positive results from phase 2 RECONNOITER trial of cilnidipine in patients with systemic sclerosis-associated Raynaud's phenomenon: Boston Monday, March 9, 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results